BRCA1 and cancer: Results of flow cytometry staining support these findings, as the baseline levels of PD-L1 positive cells were found to be significantly higher in the Brca1-deficient cancer cells in vitro when compared to Trp53−/− Brca2−/− cells (Fig. 6E).